Tracking the HUMA option chain helps you see every strike and expiry on Humacyte Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Humacyte Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of HUMA options activity at a glance. Use our scanner to monitor the HUMA option chain in real time and filter for the HUMA options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For HUMA stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the HUMA option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where HUMA stock options are being actively traded and where they are not.
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; and coronary artery bypass grafting, as well as developing its HAVs for pediatric heart surgery and cellular therapy delivery, including pancreatic islet cell transplantation to treat Type 1 diabetes.
The company was founded in 2004 and is headquartered in Durham, North Carolina.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Humacyte Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen HUMA options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of HUMA stock options — let the full option chain come to you, pre-filtered and ready to trade.
